Kestra Medical Technologies, Ltd. (KMTS) vs Syndax Pharmaceuticals, Inc. (SNDX)

A side-by-side comparison of Kestra Medical Technologies, Ltd. and Syndax Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KMTS vs SNDX

growth of $100 · dividends reinvested · last 2y
KMTS +29.8% (+13.9%/yr)SNDX +23.1% (+11.0%/yr)KMTS compounded faster over this window
100150Start $1002026$130$123
KMTS SNDX

KMTS vs SNDX: by the numbers

  • •KMTS is the larger company ($1.60B vs $1.54B market cap).
  • •Both run net losses; SNDX's is the smaller (-87.60% vs -140.43% net margin).

Metrics side by side

Valuation

MetricKMTSSNDX
P/S ratio15.026.10
P/B ratio7.21101.82

Profitability

MetricKMTSSNDX
Gross margin53.89%97.47%
Operating margin-134.48%-158.45%
Net margin-140.43%-87.60%
ROE-67.40%-1462.12%
ROIC-47.99%-32.15%

Growth (annualized)

MetricKMTSSNDX
Revenue CAGR (5Y)N/A178.06%
Total return CAGR (5Y)N/A-0.01%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.